drugset / Trial / NCT00003953
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Phase 2
Completed
39 enrolled
Case Comprehensive Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of doxorubicin and docetaxel followed by surgery in treating women who have stage II or stage III breast cancer.
Timeline
- Start
- 1999-02
- Primary completion
- 2001-11
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |
| Subject | Doxorubicin | Other / unclassified | — | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Methotrexate | Small molecule | — | — |
| Background | Tamoxifen | Small molecule | — | Oral |
| Background | filgrastim | Protein / enzyme biologic | — | Subcutaneous |
| Background | fluorouracil | Small molecule | — | — |